Boca Raton, FL –May 13, 2014 –Modernizing Medicine®, the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, specialty-specific electronic medical record (EMR) system, and Miraca Life Sciences (MLS), the nation’s largest independent anatomical pathology lab, announced today plans to launch EMA Urology™, an electronic medical records (EMR) system designed for urologists.
With specialty-specific systems for dermatology, ophthalmology, orthopedics, otolaryngology, gastroenterology and plastic and cosmetic surgery, Modernizing Medicine will expand its product portfolio with a solution for the underserved urology market that lacks a template-free, cloud solution with EMA’s features. Like the Company’s other EMA systems, EMA Urology will be available as a native iPad application with the same convenient touch-screen functionality that frees providers from tedious typing. Combined with a seamless integration with Miraca Life Sciences, providers will enjoy having additional time saved to focus on patient care.
“Our EMA iPad application lends itself particularly well to the specialty of urology,” said Modernizing Medicine’s CEO and cofounder Dan Cane. “And the need for a cloud solution like ours in the urology market makes this an ideal opportunity. With the introduction of EMA Urology already on our road map, our relationship with Miraca Life Sciences will accelerate our development plans to deliver a better EMR system to urologists much sooner than anticipated, one that is Meaningful Use-certified and ready for ICD-10.”
“As a leading pathology service provider, we’ve always had a focus on technology. We have a strong history of providing workflow efficiencies to our clients. By combining our extensive experience and expertise with Modernizing Medicine’s innovative EMR solution, together we can guide healthcare professionals towards full EHR integration to get the workflow efficiency and automation they need,” said Frank Basile, CEO of Miraca Life Sciences.
Also available from any web-enabled Mac or PC, EMA Urology will have the EMA adaptive learning engine that adjusts to a doctor’s unique style of practice and remembers preferences. Free of templates, Modernizing Medicine’s electronic health records (EHR) system eliminates cloning and documents each individual patient exam uniquely. EMA also integrates with hundreds of practice management solutions.
“One of the aspects that makes Modernizing Medicine so unique is that we have 17 practicing physicians on staff who develop EMA for their specialties. Not only that, we’ve taught them to be developers so that they actually code their medical knowledge into the system. In this respect, EMA truly is developed by doctors for doctors,” said Cane. “We already have a urologist on staff who is the team lead for EMA Urology.”
“Miraca Life Sciences will be the exclusive laboratory reseller for EMA Urology broadening the reach to urologists across the nation. Together, we are investing financial and intellectual resources in developing the industry’s most robust diagnostic integration to provide patients with the highest level of care and practices a seamless user experience. The goal is to provide higher quality pathology services to our mutual clients and improve communication between urologists and uropathologists,” shared Michael Sherling, MD, Chief Medical Officer and cofounder of Modernizing Medicine.
“Working with Modernizing Medicine is a natural fit, since we share the same goals of using technology to accelerate positive change in healthcare,” said Richard Lash, MD, Chief Medical Officer of Miraca Life Sciences. “MLS’s highly structured data derived from our consensus approach to diagnostic terminology will complement the rich clinical information provided by Modernizing Medicine, helping ensure the most definitive diagnoses for individual patients while creating a powerful database to help clinicians and pathologists improve patient outcomes.”
Modernizing Medicine anticipates a late spring unveiling of the new EMA Urology. “We will have a presence at the 2014 American Urological Association Annual Meeting in Orlando, May 16-21,” Cane said. “Urologists will be able to see a demonstration of the product that will give them a truly cloud-based solution unlike any other EMR system available for their medical specialty. Product demonstrations can be seen at Modernizing Medicine booth number 2061 and Miraca Life Sciences booth number 1871.”
About Modernizing Medicine
Modernizing Medicine® is transforming how healthcare information is created, consumed and utilized in order to increase efficiency and improve outcomes. Our product, Electronic Medical Assistant® (EMA™), is a cloud-based, specialty-specific electronic medical record (EMR) system with a massive library of built-in medical content. Available as a native iPad application or from almost any web-enabled Mac or PC, EMA adapts to each provider’s unique style of practice and is designed to interface with hundreds of different practice management systems. Today, Modernizing Medicine provides specialty-specific offerings for the dermatology, ophthalmology, orthopedics, otolaryngology, gastroenterology, urology and plastic and cosmetic surgery markets, and to more than 1,300 physician practices across the country. In 2013 Modernizing Medicine was listed on Forbes’ annual ranking of America’s Most Promising Companies.
About Miraca Life Sciences
Serving more than 5,500 patients each day, Miraca Life Sciences is a leader in providing an academic-caliber pathology laboratory with diagnostic services in the fields of dermatology, gastroenterology, hematology and urology. Building upon our experience with health IT, we also offer accessible technology solutions to assist healthcare professionals as they work towards accordance with Meaningful Use initiatives.
Miraca Life Sciences, a wholly owned subsidiary of Japan-based Miraca Holdings Inc., employs a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals — all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It’s part of our commitment: not only to scientific excellence, but to patients and practices.
For more information, contact:
Tara Auclair Ryan